About ChroniSense Medical

About ChroniSense Medical

Our Mission

ChroniSense Medical improves the lives of people managing chronic diseases by developing advanced remote patient monitoring platforms based on the company’s world-class signal processing and algorithm development capabilities. The PolsoTM multiparameter vital signs watch is the company’s lead platform, building the foundation for future AI-based algorithms and clinical use cases.

Leadership Team

With decades of experience in the industry, our team is well-positioned to carry the healthcare technology landscape forward. We are committed to creating innovative medical devices that empower patients and physicians.

Management

Bridget A. Ross

Chief Executive Officer

Bridget A. Ross

Chief Executive Officer

Prior to joining ChroniSense Medical, Bridget was President of the Global Medical Group at Henry Schein Inc., and previously held senior leadership roles at Johnson & Johnson Inc.  Bridget serves on the Board of Directors of LeMaitre Vascular Inc. (NSDQ:LMAT) and advises a number of start-up companies in the MedTech space.

Din Hadass

General Manager, CSM Israel

Din Hadass

General Manager, CSM Israel

Din has over fifteen years of senior leadership, marketing, and R&D experience in medical devices. Prior to joining ChroniSense Medical, he served as Co-CEO at Motorika (rehabilitation robots), COO at Molecular Dynamics (Molecular Imaging), and held marketing and R&D management positions at Lumenis (medical lasers), Philips Healthcare (medical imaging), and CyOptics (optical communication).

Din holds an MBA from the Haifa University, M.Sc. and B.Sc. in electrical engineering from the Technion (Israeli Institute of Technology), all Cum Laude.

Directors

Mr. Yossi Gross

Co-founder

Mr. Yossi Gross

Co-founder

Yossi is a world-renowned entrepreneur with a long and successful track record who founded over 30 med-tech companies providing innovative solutions to unmet medical needs. He has filed over 800 patents to date.

Ilan Neugarten

Executive Chairman

Ilan Neugarten

Executive Chairman

Ilan has over 35 years of senior managerial experience, and over 15 years of experience in the medical industry. He brings significant experience in medical devices, venture capital investments, commercialization, and asset realization.

Advisors

Randall Zusman,
M.D.

Medical Advisor

Randall Zusman,
M.D.

Medical Advisor

Director of the Division of Hypertension at the Massachusetts General Hospital Heart Center and Consultant in Cardiology at the Massachusetts Institute of Technology, in Boston, Massachusetts. He is also an Associate Professor of Medicine at Harvard Medical School. Dr. Zusman has recently been designated a Specialist in Clinical Hypertension by the American Society of Hypertension.

Joseph Kvedar
M.D.

Medical Advisor

Joseph Kvedar
M.D.

Medical Advisor

Joseph C. Kvedar, MD, is Professor of Dermatology at Harvard Medical School, Chair of the Board of the American Telemedicine Association (ATA), Co-chair the American Medical Association’s (AMA) Digital Medicine Payment Advisory Group (DMPAG), and Senior Advisor, Virtual Care, Mass General Brigham. Dr. Kvedar also serves as Editor-in-Chief of npj Digital Medicine, and is the author of two books on digital health: The Internet of Healthy Things and The New Mobile Age: How Technology Will Extend the Healthspan and Optimize the Lifespan.

Prof. Yehuda Shoenfeld,
M.D.

Medical Advisor

Prof. Yehuda Shoenfeld,
M.D.

Medical Advisor

Prof. Shoenfeld is a world-renowned internal medicine expert. He is founder and head of the Zabludowicz Center for Autoimmune Diseases at the Sheba Medical Center, and holds the Laura Schwarz-Kipp Chair for Research at the Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Interested in joining our team?

Get in touch with us to learn about available opportunities!

Contact Us